5
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Methadone maintenance treatment reduces heroin injection in New South Wales prisons

, &
Pages 153-158 | Received 09 Oct 1997, Accepted 13 Feb 1998, Published online: 12 Jul 2009

References

  • Ward J, Mattick R, Hall W. Key issues in methadone maintenance treatment. University of New South Wales Press, Sydney 1992
  • Joseph H. The criminal justice system and opiate addiction: a historical perspective. Compulsory treatment of drug abuse: research and clinical practice. Research monograph, C Leukfeld, F Tims. US Department of Health, Rockville 1988, In
  • Metzger DS, Woody GE, McLellan T, O'Brien CP, et al. HIV seroconversion among intravenous drug users in and out of treatment: an 18 month prospective follow up. JAIDS 1993; 6: 1049–1055
  • Caplehorn JRM, Ross MW. Methadone maintenance and the likelihood of risky needle-sharing. Int J Addict 1995; 30: 685–698
  • Hubbard RL, French MT. New perspectives on the benefit-cost and cost-effectiveness of drug abuse treatment. Economic costs, cost-effectiveness, financing and community-based drug treatment, National Institute on Drug Abuse Research Monograph Series (113). US Department of Health and Human Services, National Institute on Drug Abuse, Rockville, MD 1991; 94–113, In
  • Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. Springer-Verlag, New York 1991
  • Hall W, Ward J, Mattick R. Methadone maintenance treatment in prisons: the New South Wales experience. Drug Alcohol Rev 1993; 12: 193–203
  • Magura S, Rosenblum A, Lewis C, Joseph H. The effectiveness of in-jail methadone maintenance. J Drug Issues 1993; 23: 75–99
  • Dolan K, Wodak A. An international review of methadone provision in prisons. Addict Res 1996; 4: 85–97
  • Crofts N, Webb-Pullman J, Dolan K. An analysis of trends over time in social and behavioural factors related to the transmission of HIV among IDUs and prison inmates. AGPS, Canberra 1996
  • Gaughwin MD, Douglas RM, Wodak AD. Behind bars—risk behaviours for HIV transmission in prisons, a review. HIV/AIDS and prisons conference proceedings, J Norberry, SA Gerull, MD Gaughwin. Australian Institute of Criminology, Canberra 1991, In
  • Taylor A, Goldberg D, Emslie J, Wrench J, Gruer L, Cameron S, Black J, Davis B, McGregor J, Follett E, Harvey J, Basson J, McGavigan J. Outbreak of HIV infection in a Scottish Prison. Br Med J 1995; 310: 289–292
  • Choopanya K, Des Jarlias D, Vanichseni S, Raktham S, Kitayaporn D. Incarceration as a continuing HIV risk factor among injecting drug users in Bangkok. Presented at the IX International Conference on AIDS. 1996; 2: 47–47, abstract no. WeD 352
  • Dolan K, Wodak A, Hall W, Gaughwin M, Rae F. HIV risk behaviour before, during and after imprisonment in New South Wales. Addict Res 1996; 4: 151–160
  • Darke S, Hall W, Heather N, Ward J, Wodak A. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991; 5: 181–185
  • George JR. Serological assays for human immunodeficiency virus antibody in dried blood specimens collected on filter paper from neonates. US Department of Health and Human Services—Public Health Service, Centers for Diseases Control. 1989
  • Maskill WJ, Silvester C, Healey DS. Application of protein blotting to the serodiagnosis of human immunodeficiency virus infection. Protein blotting methodology, research and diagnostic applications, BA Baldo, ER Tovey. Karger, Basel, In
  • Corrections Health Service. Achieving excellence in health care. Annual report. Sydney 1996, 1995/96
  • Armstrong BK, White E, Saracci R. Principles of exposure measurement in epidemiology. Oxford Medical Publications, New York 1992
  • Dye S, Isaacs C. Intravenous drug misuse among prison inmates: implications for spread of HIV. Br Med J 1991; 302: 1506–1506
  • Dolan K, Wodak A, Penny R. AIDS behind bars: Preventing HIV spread among incarcerated drug injectors. AIDS 1995; 9: 825–832
  • McLellan AT. Patient characteristic associated with outcome. Research on the treatment of narcotic addiction: state of the art, JR Cooper, F Althman, BS Brown, D Czechowicz. NIDA, US Department of Health And Human Sciences, Maryland 1983, In
  • Grella CE, Anglin MD, et al. Reasons for discharge from methadone maintenance for addicts at high risk of HIV infection or transmission. J Psychoactive Drugs 1994; 26: 223–232
  • Torrens M, Castillo C, Perez-Sola V. Retention in a low threshold methadone maintenance program. Drug Alcohol Depend 1996; 41: 55–59
  • National Institute on Drug Abuse. Community Alert Bulletin. NIDA US Department of Health and Human Services, Rockville, MD March, 1993, 25
  • Dolan K, Hall W, Wodak A. Bleach availability and risk behaviour in prison in New South Wales. Technical Report No 22. National Drug and Alcohol Research Centre, Sydney, Sydney 1994
  • Dolan K, Shearer J, Hall W, Wodak A. Bleach is easier to obtain but inmates are still risk infection in New South Wales Prisons. Technical Report. National Drug and Alcohol Research Centre, Sydney 1996
  • Dolan K, Rutter S, Wodak A, Hall W, Maher L, Dixon D. Is syringe exchange feasible in a prison setting?. Med J Aust 1996; 164: 508–508
  • Dolan KA, Hall W, Wodak A. Methadone maintenance reduces injecting in prison. Br Med J 1996; 312: 1162–1162
  • Butler T, Dolan K, Ferson M, McGuiness L, Brown P, Robertson P. Hepatitis B and C in New South Wales prisons. Prevalence and risk factors. Med J Aust 1997; 166: 127–130

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.